Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Plasmodium falciparum | M18 aspartyl aminopeptidase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0087 | 0.5 | 0.5 |
Leishmania major | aspartyl aminopeptidase, putative,metallo-peptidase, Clan MH, Family M20 | 0.0087 | 0.5 | 0.5 |
Trypanosoma cruzi | metallo-peptidase, Clan MH, Family M20 | 0.0087 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0087 | 0.5 | 0.5 |
Entamoeba histolytica | aspartyl aminopeptidase, putative | 0.0087 | 0.5 | 0.5 |
Trypanosoma brucei | aspartyl aminopeptidase, putative | 0.0087 | 0.5 | 0.5 |
Echinococcus granulosus | aspartyl aminopeptidase | 0.0087 | 0.5 | 0.5 |
Schistosoma mansoni | aspartyl aminopeptidase (M18 family) | 0.0087 | 0.5 | 0.5 |
Trypanosoma cruzi | aspartyl aminopeptidase, putative | 0.0087 | 0.5 | 0.5 |
Loa Loa (eye worm) | aspartyl aminopeptidase | 0.0087 | 0.5 | 0.5 |
Entamoeba histolytica | aminopeptidase, putative | 0.0087 | 0.5 | 0.5 |
Mycobacterium leprae | PROBABLE AMINOPEPTIDASE PEPC | 0.0087 | 0.5 | 0.5 |
Plasmodium vivax | M18 aspartyl aminopeptidase, putative | 0.0087 | 0.5 | 0.5 |
Plasmodium falciparum | M18 aspartyl aminopeptidase | 0.0087 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0087 | 0.5 | 0.5 |
Echinococcus multilocularis | aspartyl aminopeptidase | 0.0087 | 0.5 | 0.5 |
Trypanosoma brucei | aspartyl aminopeptidase, putative | 0.0087 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Probable aminopeptidase PepC | 0.0087 | 0.5 | 0.5 |
Schistosoma mansoni | aspartyl aminopeptidase (M18 family) | 0.0087 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.49728 um | PUBCHEM_BIOASSAY: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). (Class of assay: confirmatory) [Related PubChem assays: 2170 (Confirmation screen (PFM18AAP inhibitors).), 1855 (Summary AID.)] | ChEMBL. | No reference |
IC50 (binding) | > 59.642 um | PUBCHEM_BIOASSAY: QFRET-based counterscreen for inhibitors of PFM18AAP: biochemical high throughput dose response assay for inhibitors of the Cathepsin L proteinase (CTSL1). (Class of assay: confirmatory) [Related pubchem assays: 2178 (Confirmation screen (PFM18AAP inhibitors).), 1855 (Summary AID.)] | ChEMBL. | No reference |
Potency (functional) | = 5.0119 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.